
FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients
Focal Inc (FOCL) is a pioneering technology firm specializing in augmented reality (AR) and virtual reality (VR) solutions that enhance user engagement across diverse sectors, including gaming, education, and training. With a strong emphasis on innovation and a commitment to high-quality immersive experiences, Focal Inc is strategically positioned to capitalize on the increasing demand for interactive digital environments. Supported by robust research and development, the company is actively expanding its product portfolio and market presence, making it a notable player in the dynamic landscape of immersive technology. As the company continues to advance its initiatives, it is well-placed for substantial growth and value generation in the era of digital transformation.
| Revenue (TTM) | $74.07M |
| Gross Profit (TTM) | $32.15M |
| EBITDA | $-22.20M |
| Operating Margin | -41.40% |
| Return on Equity | -130.50% |
| Return on Assets | -21.00% |
| Revenue/Share (TTM) | $1.98 |
| Book Value | $0.27 |
| Price-to-Book | 22.82 |
| Price-to-Sales (TTM) | 3.07 |
| EV/Revenue | 3.285 |
| EV/EBITDA | 1165.78 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 24.80% |
| Shares Outstanding | $37.48M |
| Float | $27.97M |
| % Insiders | 6.13% |
| % Institutions | 38.85% |
Volatility is currently expanding

FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on FOCL and any ticker you trade — then tracks every position and per-strategy win rate.